#072: Natalizumab (Tysabri, Tyruko) for active relapsing remitting MS
Natalizumab (Tysabri, Tyruko) is approved as disease-modifying therapy (DMT) for active RRMS with a rapidly evolving severe MS. You can read the complete article on my blog: https://ms-perspektive.com...
31 Heinä 202422min
#071: Insights into MS treatment in Colombia with neurologist Dr. Adriana Casallas Vanegas
Dr. Adriana Casallas V. provides insights into the treatment and care of MS patients in Colombia including improvements and challenges. You can find all questions and answers to read through on my blo...
24 Heinä 202441min
#070: Teriflunomide (Aubagio) for relapsing remitting MS
Teriflunomide (Aubagio) is approved as disease-modifying therapy for mild to moderate RRMS from 10 years of age. You can find the full article to read on my blog: https://ms-perspektive.com/70-teriflu...
17 Heinä 202419min
#069: Beyond Boundaries. Advocacy, Research, and Recognition in MS with Rachel Horne
MS patient and advocate Rachel Horne sponsors a prize for women in MS research and campaigns for more diversity in clinical trials. You can read all questions and answers on my blog: https://ms-perspe...
10 Heinä 20241h
#068: Interferon-beta (Avonex, Betaferon, Extavia, Plegridy, Rebif, …) for CIS, RRMS & SPMS
Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS. You can find the full article to read on my blog: https://ms...
3 Heinä 202421min
#067: MS Speech Therapy Insights. Enhancing Communication and Swallowing
Discover how speech therapists can address often overlooked MS-related swallowing and communication disorders for timely intervention. You can find the written version to read on my blog: https://ms-p...
26 Kesä 202416min
#066: Pioneering Paths. Empowering Young Minds in MS & NMO Research with Dr. Sara Samadzadeh
Dr. Sara Samadzadeh contributes to research in the field of NMOSD and MS by creating networks between young researchers worldwide. You can find all questions and answers as well as all links on the bl...
19 Kesä 202449min
#065: Glatiramer Acetate (Copaxone, Brabio) for relapsing remitting multiple sclerosis
Glatiramer Acetate, brand names Copaxone and Brabio, belongs to the oldest immunotherapies for relapsing remitting multiple sclerosis. You can find the written version of this episode on my blog: http...
12 Kesä 202418min
